Research Article
Hypervolemia for Hypertension Pathophysiology: A Population-Based Study
Table 1
Characteristics of the study population (
).
| | | (%) |
| | Gender | | | Male | 1456 (71.6) | | Female | 578 (28.4) | | Age groups | | | <65 | 1870 (91.9) | | ≥65 | 164 (8.1) | | Geographical region | | | Central Anatolia | 323 (15.9) | | Mediterranean | 141 (6.9) | | Aegean | 578 (28.4) | | East Anatolia | 626 (30.8) | | Southeastern Anatolia | 366 (18) | | Measurement time | | | Morning (<12 o’clock) | 649 (31.9) | | Afternoon (≥12 o’clock) | 1385 (68.1) | | Disease history | | | Healthy | 1250 (61.5) | | Diabetics | 240 (11.8) | | Known HT | 380 (18.7) | | CAD | 87 (4.3) | | COPD | 41 (2) | | CKD | 47 (2.9) | | Anti-HT | | | ACEi/ARB | 96 (4.7) | | Beta blockers | 50 (2.5) | | CCB | 18 (0.9) | | Diuretics | 7 (0.3) |
|
|
The number of subjects is crude (unadjusted) figures.
HT: hypertension, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, CKD: chronic kidney disease, ACEi: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, and CCB: calcium channel blockers.
|
